Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.9K Buy
+200
New +$26.2K ﹤0.01% 5705
2025
Q3
Sell
-300
Closed -$38.8K 7444
2025
Q2
$38.8K Buy
+300
New +$36.3K ﹤0.01% 5596

Other funds holding XYL

Wells Fargo's XYL Position: Q1 2026 in Review

Wells Fargo reduced its Xylem (XYL) stake by 1.8% in Q1 2026, selling an estimated $4.71M and leaving 1,982,928 shares worth $237M. The position accounts for 0.04% of the portfolio, ranked #351.

Wells Fargo first reported a position in XYL in Q2 2013 and has held it in 52 quarters since. The position peaked at $293M in Q3 2025. 1,108 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Wells Fargo held 1,982,928 shares of Xylem worth $237M as of Q1 2026.
  • Wells Fargo sold 35,920 Xylem shares in Q1 2026, an estimated $4.71M.
  • Xylem made up 0.04% of Wells Fargo's portfolio in Q1 2026, its #351 holding.
  • Wells Fargo first reported a position in Xylem in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Xylem position peaked at $293M in Q3 2025.
  • 1,108 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.